{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T12:28:37Z","timestamp":1789216117770,"version":"build-2803163510"},"reference-count":38,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1124\/dmd.108.023077","type":"journal-article","created":{"date-parts":[[2008,8,26]],"date-time":"2008-08-26T00:54:27Z","timestamp":1219712067000},"page":"2277-2286","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":99,"title":["Modulation of Cytochrome P450 Gene Expression and Arachidonic Acid Metabolism during Isoproterenol-Induced Cardiac Hypertrophy in Rats"],"prefix":"10.1016","volume":"36","author":[{"given":"Beshay N.M.","family":"Zordoky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona E.","family":"Aboutabl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayman O.S.","family":"El-Kadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.108.023077_bib1","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1124\/dmd.105.008185","article-title":"Cytochrome P450 gene induction in rats ex vivo assessed by quantitative real-time reverse transcriptase-polymerase chain reaction (TaqMan)","volume":"34","author":"Baldwin","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.108.023077_bib2","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1016\/S0024-3205(01)01241-3","article-title":"l-NAME prevents in vivo the inactivation but not the down-regulation of hepatic cytochrome P450 caused by an acute inflammatory reaction","volume":"69","author":"Barakat","year":"2001","journal-title":"Life Sci"},{"key":"10.1124\/dmd.108.023077_bib3","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/jbt.10","article-title":"Use of real-time gene-specific polymerase chain reaction to measure RNA expression of three family members of rat cytochrome P450 4A","volume":"15","author":"Bleicher","year":"2001","journal-title":"J Biochem Mol Toxicol"},{"key":"10.1124\/dmd.108.023077_bib4","doi-asserted-by":"crossref","first-page":"IV14","DOI":"10.1161\/circ.102.suppl_4.IV-14","article-title":"Congestive heart failure: fifty years of progress","volume":"102","author":"Braunwald","year":"2000","journal-title":"Circulation"},{"key":"10.1124\/dmd.108.023077_bib5","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0165-6147(00)01472-3","article-title":"New role for epoxyeicosatrienoic acids as anti-inflammatory mediators","volume":"21","author":"Campbell","year":"2000","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/dmd.108.023077_bib6","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1157\/13087900","article-title":"Cardiac hypertrophy: molecular and cellular events","volume":"59","author":"Carre\u00f1o","year":"2006","journal-title":"Rev Esp Cardiol"},{"key":"10.1124\/dmd.108.023077_bib7","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.vph.2007.05.005","article-title":"Effects of chronic cytochrome P-450 inhibition on the course of hypertension and end-organ damage in Ren-2 transgenic rats","volume":"47","author":"Ch\u00e1bov\u00e1","year":"2007","journal-title":"Vascul Pharmacol"},{"key":"10.1124\/dmd.108.023077_bib8","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1124\/dmd.32.8.840","article-title":"Metabolism of retinoids and arachidonic acid by human and mouse cytochrome P450 1b1","volume":"32","author":"Choudhary","year":"2004","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.108.023077_bib9","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1124\/dmd.106.012823","article-title":"Detection of human CYP2C8, CYP2C9 and CYP2J2 in cardiovascular tissues","volume":"35","author":"Delozier","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.108.023077_bib10","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.pharmthera.2005.05.011","article-title":"Cytochrome P450 enzymes: central players in cardiovascular health and disease","volume":"112","author":"Elbekai","year":"2006","journal-title":"Pharmacol Ther"},{"key":"10.1124\/dmd.108.023077_bib11","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1080\/00498250500356373","article-title":"Styrene monomer primarily induces CYP2B1 mRNA in rat liver","volume":"35","author":"Hirasawa","year":"2005","journal-title":"Xenobiotica"},{"key":"10.1124\/dmd.108.023077_bib12","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1161\/hc0402.102863","article-title":"Involvement of nuclear factor-kappaB and apoptosis signal-regulating kinase 1 in G-protein-coupled receptor agonist-induced cardiomyocyte hypertrophy","volume":"105","author":"Hirotani","year":"2002","journal-title":"Circulation"},{"key":"10.1124\/dmd.108.023077_bib13","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1161\/hy0202.103788","article-title":"Soluble epoxide hydrolase inhibition lowers arterial blood pressure in angiotensin II hypertension","volume":"39","author":"Imig","year":"2002","journal-title":"Hypertension"},{"key":"10.1124\/dmd.108.023077_bib14","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1124\/dmd.30.9.1022","article-title":"Sexual dimorphism and tissue specificity in the expression of CYP4F forms in Sprague Dawley rats","volume":"30","author":"Kalsotra","year":"2002","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.108.023077_bib15","doi-asserted-by":"crossref","first-page":"7561","DOI":"10.1016\/S0021-9258(20)89484-8","article-title":"Endogenous epoxyeicosatrienoyl-phospholipids: a novel class of cellular glycerolipids containing epoxidized arachidonate moieties","volume":"266","author":"Karara","year":"1991","journal-title":"J Biol Chem"},{"issue":"Suppl 2","key":"10.1124\/dmd.108.023077_bib16","first-page":"583","article-title":"Electrocardiography in two models of isoproterenol-induced left ventricular remodelling","volume":"57","author":"Kralova","year":"2008","journal-title":"Physiol Res"},{"key":"10.1124\/dmd.108.023077_bib17","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1146\/annurev.pharmtox.45.120403.100045","article-title":"Regulation and inhibition of arachidonic acid omega-hydroxylases and 20-HETE formation","volume":"45","author":"Kroetz","year":"2005","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1124\/dmd.108.023077_bib18","doi-asserted-by":"crossref","first-page":"12912","DOI":"10.1016\/S0021-9258(18)31472-8","article-title":"Formation of 19(S)-,19(R)-, and 18(R)-hydroxyeicosatetraenoic acids by alcohol-inducible cytochrome P450 2E1","volume":"268","author":"Laethem","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.108.023077_bib19","doi-asserted-by":"crossref","first-page":"R888","DOI":"10.1152\/ajpregu.00482.2003","article-title":"Cytochrome P-450 metabolites in endothelin-stimulated cardiac hormone secretion","volume":"286","author":"Lee","year":"2004","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1124\/dmd.108.023077_bib20","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1124\/dmd.108.023077_bib21","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J Biol Chem"},{"issue":"Suppl 1","key":"10.1124\/dmd.108.023077_bib22","first-page":"39","article-title":"B-type natriuretic peptide: a myocyte-specific marker for characterizing load-induced alterations in cardiac gene expression","volume":"30","author":"Magga","year":"1998","journal-title":"Ann Med"},{"key":"10.1124\/dmd.108.023077_bib23","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1006\/jmcc.1998.0714","article-title":"Remodelling of cardiac extracellular matrix during beta-adrenergic stimulation: upregulation of SPARC in the myocardium of adult rats","volume":"30","author":"Masson","year":"1998","journal-title":"J Mol Cell Cardiol"},{"key":"10.1124\/dmd.108.023077_bib24","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/ng.129","article-title":"Soluble epoxide hydrolase is a susceptibility factor for heart failure in a rat model of human disease","volume":"40","author":"Monti","year":"2008","journal-title":"Nat Genet"},{"key":"10.1124\/dmd.108.023077_bib25","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1124\/dmd.106.013839","article-title":"Cytochrome P450 eicosanoids are activators of peroxisome proliferator-activated receptor alpha","volume":"35","author":"Ng","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.108.023077_bib26","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1006\/abio.2001.5395","article-title":"Liquid chromatographic-electrospray ionization-mass spectrometric analysis of cytochrome P450 metabolites of arachidonic acid","volume":"298","author":"Nithipatikom","year":"2001","journal-title":"Anal Biochem"},{"key":"10.1124\/dmd.108.023077_bib27","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S1471-4914(03)00114-X","article-title":"The molecular basis of myocardial hypertrophy and heart failure","volume":"9","author":"Ritter","year":"2003","journal-title":"Trends Mol Med"},{"key":"10.1124\/dmd.108.023077_bib28","first-page":"216","article-title":"Downregulation of the atrial natriuretic peptide\/natriuretic peptide receptor-C system in the early stages of diabetic retinopathy in the rat","volume":"11","author":"Roll\u00edn","year":"2005","journal-title":"Mol Vis"},{"key":"10.1124\/dmd.108.023077_bib29","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1152\/physrev.00021.2001","article-title":"P-450 metabolites of arachidonic acid in the control of cardiovascular function","volume":"82","author":"Roman","year":"2002","journal-title":"Physiol Rev"},{"key":"10.1124\/dmd.108.023077_bib30","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1038\/sj.bjp.0703465","article-title":"Cytochrome P450 mono-oxygenase gene expression and protein activity in cultures of adult cardiomyocytes of the rat","volume":"130","author":"Thum","year":"2000","journal-title":"Br J Pharmacol"},{"key":"10.1124\/dmd.108.023077_bib31","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/S0140-6736(00)99016-0","article-title":"Gene expression in distinct regions of the heart","volume":"355","author":"Thum","year":"2000","journal-title":"Lancet"},{"key":"10.1124\/dmd.108.023077_bib32","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1096\/fj.02-0138com","article-title":"Testosterone, cytochrome P450, and cardiac hypertrophy","volume":"16","author":"Thum","year":"2002","journal-title":"FASEB J"},{"key":"10.1124\/dmd.108.023077_bib33","first-page":"F246","article-title":"Contribution of cytochrome P-450 4A1 and 4A2 to vascular 20-hydroxyeicosatetraenoic acid synthesis in rat kidneys","volume":"276","author":"Wang","year":"1999","journal-title":"Am J Physiol"},{"key":"10.1124\/dmd.108.023077_bib34","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1006\/abbi.1996.0554","article-title":"Cloning, sequencing, and cDNA-directed expression of the rat renal CYP4A2: arachidonic acid omega-hydroxylation and 11,12-epoxidation by CYP4A2 protein","volume":"336","author":"Wang","year":"1996","journal-title":"Arch Biochem Biophys"},{"key":"10.1124\/dmd.108.023077_bib35","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1124\/dmd.31.6.773","article-title":"Induction of hepatic phase II drug-metabolizing enzymes by 1,7-phenanthroline in rats is accompanied by induction of MRP3","volume":"31","author":"Wang","year":"2003","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.108.023077_bib36","doi-asserted-by":"crossref","first-page":"18733","DOI":"10.1073\/pnas.0609158103","article-title":"Prevention and reversal of cardiac hypertrophy by soluble epoxide hydrolase inhibitors","volume":"103","author":"Xu","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1124\/dmd.108.023077_bib37","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.vascn.2007.06.001","article-title":"H9c2 cell line is a valuable in vitro model to study the drug metabolizing enzymes in the heart","volume":"56","author":"Zordoky","year":"2007","journal-title":"J Pharmacol Toxicol Methods"},{"key":"10.1124\/dmd.108.023077_bib38","doi-asserted-by":"crossref","first-page":"122","DOI":"10.2174\/138920008783571792","article-title":"Modulation of cardiac and hepatic cytochrome P450 enzymes during heart failure","volume":"9","author":"Zordoky","year":"2008","journal-title":"Curr Drug Metab"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624018476?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624018476?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.108.023077","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T16:30:40Z","timestamp":1739896240000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624018476"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":38,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["S0090955624018476"],"URL":"https:\/\/doi.org\/10.1124\/dmd.108.023077","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2008,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modulation of Cytochrome P450 Gene Expression and Arachidonic Acid Metabolism during Isoproterenol-Induced Cardiac Hypertrophy in Rats","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.108.023077","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2008 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}